Printer Friendly

Articles from MondayMorning (July 26, 2010)

1-25 out of 25 article(s)
Title Author Type Words
(7) it's official: Carlyle, TPG agree to buy Healthscope. Carlyle Group. 407
A new AIDS drug from GlaxoSmithKline Plc (Brentford UK) and its partner Shionogi & Co Ltd (Osaka, Japan) works faster and has fewer side effects than Bristol-Myers Squibb's (New York) older medicine Sustiva, researchers said. 772
A vaginal gel containing Gilead Sciences Inc's (Foster City CA) AIDS drug Viread cut HIV infections by as much as 54% in a trial in South Africa, the first time such a product has protected women after six previous gels failed. 385
Abbott Laboratories Inc. 276
Amylin Pharmaceuticals Inc (San Diego CA) said that its second-quarter loss narrowed on lower costs, offseting a continued decline in sales of the diabetes drug Byetta. Financial report 223
Biogen 2Q profit doubles without Acorda Payment. Biogen Idec Inc. Financial report 290
Boston Scientific Corp. 269
FDA roundup: Glenmark Generics Ltd. Company overview 1421
GlaxoSmithKline Plc. 236
IPO sector. 130
J&J's 2Q net rises despite recalls. 415
Jump in enrollment boosts UnitedHealth's 2Q results. 227
Lilly, Bristol-Myers 2Q profits resist price pressures. Financial report 346
Markets: investors bought stocks again Friday on the latest reassuring news about the economy. 363
Medical clinic billing and records software maker AthenaHealth Inc (Watertown MA) said that its second-quarter profit fell as expenses outweighed a revenue boost. Financial report 135
Medical device maker Saint Jude Medical Inc (Saint Paul MN) said that its net income rose 16% during the second quarter on a boost in heart device sales. Brief article 193
Medical stock spotlight: Cypress BioPharma Inc. 800
Potent stem cells derived from reprogramming skin or other adult body tissues may have limits on their usefulness as an alternative to cells from human embryos, researchers said. 397
Quest Diagnostics Inc (Madison NJ) reported that second-quarter net income climbed 3%, yet the medical laboratory operator cut its annual guidance because of falling revenue. Financial report 229
Roche Holding AG. 239
Sanofi-Aventis rumored to bid for Genzyme. Sanofi-Aventis SA. 280
Tougher conflict policy emerges at Harvard Medical School. 357
Tracking Washington. 162
Weekly key rates. Brief article 111
Weekly stock performance. Statistical table 461

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters